Primary Site >> Pancreatic Cancer
Gene >> SPTBN1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma. PMID: 10052247 |
Ref: CPT-11 in gastrointestinal cancer. PMID: 10448285 |
Ref: A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413). PMID: 10958597 |
Ref: Optical markers in duodenal mucosa predict the presence of pancreatic cancer. PMID: 17671121 |
Ref: Epigenetic silencing of beta-spectrin, a TGF-beta signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome. PMID: 20739274 Ref: Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer. PMID: 20886430 |
Ref: Bicluster and pathway enrichment analysis related to tumor progression of hepatocellular carcinoma. PMID: 25912578 |